#heartattack Tag

08 Nov

Posted at 16:58h in Author Interviews

Health Notice: This interview discusses research findings and is not medical advice. If you are concerned about your cannabis use, talk with your healthcare provider or call the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7). If you are in crisis, call or text 988. Call 911 right away for chest pain or pressure, shortness of breath, sudden weakness or numbness on one side of the body, trouble speaking, or a sudden severe headache.

[caption id="attachment_70106" align="alignleft" width="150"]Raphael E. Cuomo, PhD Professor of Medicine University of California, San Diego Prof. Cuomo[/caption]

MedicalResearch.com Interview with: Raphael E. Cuomo, PhD, MPH, CPH, FRSPH Associate Adjunct Professor, Anesthesiology University of California, San Diego

08 Oct

Posted at 17:04h in Heart Disease

Heart Health Notice: If you have chest pain or pressure, shortness of breath, pain spreading to the arm, jaw, neck, or back, cold sweat, nausea, or sudden dizziness, call 911 or your local emergency number right away. Do not drive yourself to the hospital. This article is for general education and does not replace advice from your doctor. Do not start, stop, or change any medication, or begin a new exercise program if you have heart disease or symptoms, without talking to your healthcare provider. Programs, tests, and services mentioned or linked here are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc.

Many heart attacks seem to come out of nowhere. A person feels fine on Monday and ends up in the hospital on Friday. But the damage usually starts years before. Plaque slowly builds inside the arteries, and most people never feel it happening. The good news is that you can act early. The first step is to know your own risk factors. When you know what puts your heart at risk, you can work with your doctor to address those things before they cause harm. [caption id="attachment_76521" align="aligncenter" width="500"]how-to-help-prevent-heart-attacks-pexels Photo by freestocks.org: [/caption]

06 Nov

Posted at 14:24h in Author Interviews, Heart Disease
MedicalResearch.com Interview with: [caption id="attachment_61006" align="alignleft" width="125"]Prakriti Gaba, MDCardiovascular Medicine Fellow Brigham and Women's Hospital Dr. Gaba[/caption] Prakriti Gaba, MD Cardiovascular Medicine Fellow Brigham and Women's Hospital [caption id="attachment_31114" align="alignleft" width="120"]Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center Professor of Medicine, Harvard Medical School Boston, MA 02115 Dr. Deepak  Bhatt[/caption] Deepak L. Bhatt MD MPH Director of Mount Sinai Fuster Heart Hospital Dr. Valentin Fuster Professor of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study?  Response: Accurate classification of acute myocardial infarction is instrumental for the appropriate diagnosis and effective management of patients suffering from this widely prevalent cardiovascular condition. In the past, there have been a variety of clinical scores published to advise clinicians on the best classifications schemes for patients with acute MI. These have included the Thrombolysis in Myocardial Infarction (TIMI) risk score, the HEART score, and the Killip classification. The strength of these traditional scores includes their practicality, as they can be implemented at the bedside to rapidly assist with prognostication. Nonetheless, as technologic advancements have made imaging and tissue identification more accessible, national and international committees are looking to revise traditional classification schemes of acute MI with novel ones leveraging multimodal approaches.

28 Feb

Posted at 15:14h in Author Interviews, Heart Disease, Race/Ethnic Diversity
MedicalResearch.com Interview with: [caption id="attachment_60103" align="alignleft" width="125"]Dr. Muchi Ditah Chobufo MD MPHCardiology Fellow West Virginia University Dr. Ditah Chobufo[/caption] Dr. Muchi Ditah Chobufo MD MPH Cardiology Fellow West Virginia University MedicalResearch.com: What is the background for this study? Response: Ischemic heart diseases are a significant cause of morbidity and mortality in the USA. Also, there exists alarming ethnic disparities in mortality rates following acute myocardial infarction. To this effect, significant efforts have been deployed over the years to curb its burden and reduce extant disparities. It is in this light that we set out to analyze general and ethnic specific trends in acute myocardial infarction related age adjusted mortality rates (AAMR) in the entire USA from 1999-2020. 

05 Oct

Posted at 19:15h in Author Interviews, Biomarkers, Heart Disease, JAMA, Technology
MedicalResearch.com Interview with: [caption id="attachment_58206" align="alignleft" width="200"]Pinar Zorlutuna, PhD Sheehan Family Collegiate Professor of Engineering Aerospace and Mechanical Engineering  Chemical and Biomolecular Engineering (Concurrent) Bioengineering Graduate Program  University of Notre Dame Dr. Zorlutuna[/caption] Pinar Zorlutuna, PhD Sheehan Family Collegiate Professor of Engineering Aerospace and Mechanical Engineering Chemical and Biomolecular Engineering (Concurrent) Bioengineering Graduate Program University of Notre Dame  MedicalResearch.com: What is the background for this study? Response: Acute myocardial infarction (AMI) is the primary cause of death among cardiovascular diseases. The current clinical standard of diagnosis combines echocardiogram (ECG) and several circulating protein biomarkers from plasma. In their current state, both are incapable of distinguishing between patients with and without complete coronary occlusion, unless additional invasive testing is implemented, and both have significant false positive rates. MicroRNAs (miRNAs) have shown great potential as rapid and discriminating biomarkers for acute myocardial infarction (AMI) diagnosis.

03 Sep

Posted at 11:34h in Author Interviews, Heart Disease, NEJM, Salt-Sodium, Stroke
[caption id="attachment_58038" align="alignleft" width="265"]Maoyi TIAN PhD Program Head, Digital Health and Head, Injury & Trauma Senior Research Fellow The George Institute Dr. Tian[/caption] MedicalResearch.com Interview with: Maoyi TIAN PhD Program Head, Digital Health and Head, Injury & Trauma Senior Research Fellow The George Institute MedicalResearch.com: What is the background for this study? Response: There is clear evidence from the literature that sodium reduction or potassium supplementation can reduce blood pressure. Reduced blood pressure can also lead to a risk reduction for cardiovascular diseases. Salt substitute is a reduced sodium added potassium product combined those effects. Previous research of salt substitute focus on the blood pressure outcome. There is no evidence if salt substitute can reduce the risk of cardiovascular diseases or pre-mature death. This study provided a definitive evidence for this unaddressed question. MedicalResearch.com: What are the main findings? The main findings of the research were:
  • The salt substitute reduced the risk of stroke by 14%
  • The salt substitute reduced the risk of major adverse cardiovascular events by 13%
  • The salt substitute reduced the risk of pre-mature death by 12%